FinTrust Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
FinTrust Capital Advisors's GILD Position: Q3 2024 in Review
FinTrust Capital Advisors increased its Gilead Sciences (GILD) stake by 1% in Q3 2024, buying an estimated $1.07K and bringing the position to 1,368 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #399.
FinTrust Capital Advisors first reported a position in GILD in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.56M in Q2 2020. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- FinTrust Capital Advisors held 1,368 shares of Gilead Sciences worth $115K as of Q3 2024.
- FinTrust Capital Advisors bought 14 Gilead Sciences shares in Q3 2024, an estimated $1.07K.
- Gilead Sciences made up 0.02% of FinTrust Capital Advisors's portfolio in Q3 2024, its #399 holding.
- FinTrust Capital Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 24 quarters since.
- FinTrust Capital Advisors's Gilead Sciences position peaked at $1.56M in Q2 2020.
- 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.